Periscope Capital Inc. Makes New Investment in GP-Act III Acquisition Corp. (NASDAQ:GPAT)

Periscope Capital Inc. bought a new position in GP-Act III Acquisition Corp. (NASDAQ:GPATFree Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 275,000 shares of the company’s stock, valued at approximately $2,772,000. GP-Act III Acquisition comprises about 1.5% of Periscope Capital Inc.’s portfolio, making the stock its 20th largest position.

Other hedge funds have also modified their holdings of the company. Wolverine Asset Management LLC bought a new position in GP-Act III Acquisition in the 3rd quarter worth approximately $2,894,000. Wealthspring Capital LLC bought a new stake in shares of GP-Act III Acquisition during the third quarter worth $2,560,000. PNC Financial Services Group Inc. acquired a new position in shares of GP-Act III Acquisition during the third quarter valued at $1,613,000. Finally, Dakota Wealth Management bought a new position in GP-Act III Acquisition in the third quarter valued at about $488,000.

GP-Act III Acquisition Price Performance

Shares of NASDAQ:GPAT opened at $10.08 on Friday. GP-Act III Acquisition Corp. has a 1-year low of $9.98 and a 1-year high of $10.10. The stock’s 50-day moving average price is $10.07.

GP-Act III Acquisition Company Profile

(Free Report)

We are a blank check company incorporated as a Cayman Islands exempted company whose business purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.

Read More

Want to see what other hedge funds are holding GPAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GP-Act III Acquisition Corp. (NASDAQ:GPATFree Report).

Institutional Ownership by Quarter for GP-Act III Acquisition (NASDAQ:GPAT)

Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.